(Q28373322)

2

0 references

S Bhendwal

3

0 references

W R Ramey

4

0 references

H Shirin

5

0 references

B S Reddy

6

0 references

P R Holt

Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells

7

0 references

language of work or name

English

0 references

publication date

October 1999

0 references

published in

Gastroenterology

0 references

volume

117

0 references

issue

4

0 references

page(s)

838-47

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970342-2

Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970342-2

Influence of various prostaglandin synthesis inhibitors on DMH-induced rat colon cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970342-2

Effect of piroxicam on primary intestinal tumors induced in rats by N-methylnitrosourea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970342-2

Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970342-2

Sulindac therapy of colorectal polyps in familial adenomatous polyposis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970342-2

Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970342-2

Sulindac suppresses tumorigenesis in the Min mouse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970342-2

Aspirin use and reduced risk of fatal colon cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970342-2

Tissue prostaglandin levels in familial adenomatous polyposis patients treated with sulindac

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970342-2

Complete reversion and prevention of rectal adenomas in colectomized patients with familial adenomatous polyposis by rectal low-dose sulindac maintenance treatment. Advantages of a low-dose nonsteroidal anti-inflammatory drug regimen in reversing ad

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970342-2

Prostaglandin levels in human colorectal mucosa: effects of sulindac in patients with familial adenomatous polyposis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970342-2

Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970342-2

Regulation of the mevalonate pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970342-2

Farnesol modification of Kirsten-ras exon 4B protein is essential for transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970342-2

Lovastatin induces growth inhibition and apoptosis in human malignant glioma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970342-2

Lovastatin-induced apoptosis in prostate stromal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970342-2

Lovastatin inhibits proliferation and differentiation and causes apoptosis in lipopolysaccharide-stimulated murine B cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970342-2

Inhibition of isoprenoid biosynthesis induces apoptosis in human promyelocytic HL-60 cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970342-2

The effects of pravastatin, an HMG-CoA reductase inhibitor, on cell viability and DNA production of rat hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970342-2

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970342-2

Chemoprevention by pravastatin, a 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, of N-methyl-N-nitrosourea-induced colon carcinogenesis in F344 rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970342-2

Chemopreventive efficacy of low dose of pravastatin, an HMG-CoA reductase inhibitor, on 1,2-dimethylhydrazine-induced colon carcinogenesis in ICR mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970342-2

Chemoprevention of colon cancer by organoselenium compounds and impact of high- or low-fat diets.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970342-2

Labelling DNA strand breaks with BrdUTP. Detection of apoptosis and cell proliferation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970342-2

Increased intestinal Bak expression results in apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970342-2

Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970342-2

Prostaglandin H synthase expression is variable in human colorectal adenocarcinoma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970342-2

Apoptosis and APC in colorectal tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970342-2

The interactions of APC, E-cadherin and beta-catenin in tumour development and progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970342-2

Experimentally induced cancer of the colon.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970342-2

Aberrant crypt foci of the colon as precursors of adenoma and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970342-2

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970342-2

Farnesyl: proteintransferase inhibitors as agents to inhibit tumor growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970342-2

Evidence that farnesyltransferase inhibitors suppress Ras transformation by interfering with Rho activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970342-2

Aberrant crypts in human colonic mucosa: putative preneoplastic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970342-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0016-5085(99)70342-2

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

10500066

1 reference

Consolidated OpenCitations Corpus – April 2017